Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetics of Intravesical Instillation of EO9 in Patients With Non-muscle Invasive Bladder Cancer(NMIBC).
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2012
At a glance
- Drugs Apaziquone; Apaziquone
- Indications Bladder cancer
- Focus Adverse reactions
- 12 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Jun 2011 New trial record